| Website | americastemcell.com |
| Category | BioTech |
| Phone | 760.612.6277 |
| Employees | |
| Founded | 2005 |
| Description | biotechnology company |
| Unattributed, 7/09 The Texas Emerging Technology Fund | $2.5M |
America Stem Cell, Inc. (ASC) is a privately held biotechnology company dedicated to the development and commercialization of enabling technologies to enhance and expand the therapeutic potential of stem cell transplants.
The Company is engaged in the development of stem cell enabling technologies and the key technology platforms – ASC-101 and ASC-201 – are designed to improve the engraftment of stem cells to target organs and increase their therapeutic potential.
Founded in 2005, ASC is led by an experienced management team and has established a prominent board of advisors to guide its technology development programs. The Company has established a number of strategic partnerships with medical research institutions including the University of Texas M.D. Anderson Cancer Center, the Oklahoma Medical Research Foundation, and VidaCord Technologia Biomedica.
